Percentages of Annexin V‐positive cells after treatment with volasertib in both p53 wild‐type (A549 and A549‐NTC) and p53 nonfunctional (A549‐920 and NCI‐H1975) NSCLC cell lines. This evidence concerns the gene TP53 and non-small cell lung carcinoma.